Real-world data on the efficacy and safety of weekly oral vinorelbine in breast cancer patients previously treated with anthracycline or taxane-based regimens-Reference-Cited by-同舟云学术

Real-world data on the efficacy and safety of weekly oral vinorelbine in breast cancer patients previously treated with anthracycline or taxane-based regimens

Published:2018-10-06 Issue:4 Volume:21 Page:459-466
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Blancas I.^ORCID,Aguirre E.,Morales S.,Gonzálvez M. L.,Servitja S.,Díaz N.,del Barco S.,Barnadas A.,Margelí M.,García Carbonero I.,Llombart A.

Funder

Pierre Fabre

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12094-018-1946-9.pdf

Reference30 articles.

1. Rabow M, Small R, Jow A, Majure M, Chien A, Melisko M, et al. The value of embedding: integrated palliative care for patients with metastatic breast cancer. Breast Cancer Res Treat. 2018;167(3):703–8. https://doi.org/10.1007/s10549-017-4556-2 .

2. Fedele P, Ciccarese M, Surico G, Cinieri S. An update on first line therapies for metastatic breast cancer. Expert Opin Pharmacother. 2018;19(3):243–52. https://doi.org/10.1080/14656566.2018.1425680 .

3. Greenberg PA, Hortobagyi GN, Smith TL, Ziegler LD, Frye DK, Buzdar AU. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol. 1996;14(8):2197–205.

4. Cancer B. Fact sheet. 2016. http://www.moph.gov.lb/Campaigns/Materials/FactSheet.pdf . Accessed 07 May 2018.

5. Heinemann V, Di Gioia D, Vehling-Kaiser U, Harich HD, Heinrich B, Welt A, et al. A prospective multicenter phase II study of oral and i.v. vinorelbine plus trastuzumab as first-line therapy in HER2-overexpressing metastatic breast cancer. Ann Oncol. 2011;22(3):603–8. https://doi.org/10.1093/annonc/mdq409 .

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Chidamide in Combination with PD-1 Inhibitor and Radiotherapy for HER2-Negative Advanced Breast Cancer: Study Protocol of a Single Arm Prospective Study;Cancer Management and Research;2024-06

2. The efficiency and safety of low‐dose apatinib combined with oral vinorelbine in pretreated HER2‐negative metastatic breast cancer;Cancer Medicine;2024-04

3. Oral Etoposide and Trastuzumab Use for HER2-Positive Metastatic Breast Cancer: A Retrospective Study from the Institut Curie Hospitals;Cancers;2022-04-24

4. A Real-World Study on Oral Vinorelbine for the Treatment of Metastatic Breast Cancer;Oncologie;2022

5. Phase II study of metronomic treatment with daily oral vinorelbine as first-line chemotherapy in patients with advanced/metastatic HR+/HER2− breast cancer resistant to endocrine therapy: VinoMetro—AGO-B-046;Journal of Cancer Research and Clinical Oncology;2021-03-20